Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Provectus Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?

To: jm2i123 who wrote (11957)	5/17/2013 12:47:57 PM
From: NTTG	1 Recommendation Respond to of 13111

YEA, I want to see the rocket take off...that '10 bagger' the longs have been talk about forever. But the launch date keeps getting delayed, countdown on hold...waiting and waiting and.... but for the record, since the PIII will likely focus on non-progressing stage III disease patients and the selection of a comparator is out of the control of the company, the injection dosing and timing will be key in order to see a meaningful difference in primary endpoint response. Will be interesting to see what limits are placed into the PV-10 dosing protocol. Upfront and milestone payment structure will be most interesting to see ...still waiting